Aberrant expression of lysophosphatidic acid (LPA) receptors in human colorectal cancer
- 1 October 2004
- journal article
- Published by Elsevier in Laboratory Investigation
- Vol. 84 (10) , 1352-1362
- https://doi.org/10.1038/labinvest.3700146
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- The emerging role of lysophosphatidic acid in cancerNature Reviews Cancer, 2003
- Lysophospholipids--Receptor RevelationsScience, 2001
- Lysophospholipids Increase Interleukin-8 Expression in Ovarian Cancer CellsGynecologic Oncology, 2001
- Bioactive Lysophospholipids and Their G Protein-Coupled ReceptorsExperimental Cell Research, 1999
- NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, EICOSANOIDS, AND COLORECTAL CANCER PREVENTIONGastroenterology Clinics of North America, 1996
- Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptorsNature, 1996
- Lysophosphatidic Acid, a Multifunctional Phospholipid MessengerJournal of Biological Chemistry, 1995
- The Min (multiple intestinal neoplasia) mutation: its effect on gut epithelial cell differentiation and interaction with a modifier system.The Journal of cell biology, 1992
- A Dominant Mutation That Predisposes to Multiple Intestinal Neoplasia in the MouseScience, 1990
- Genetic Alterations during Colorectal-Tumor DevelopmentNew England Journal of Medicine, 1988